ContactSenators

Who in Congress trades NVS?

Novartis AG

5 members of Congress have disclosed 10 NVS transactions between March 31, 2016 – March 31, 2026. Under the STOCK Act these must be filed within 45 days of the trade.

10
transactions
5
members
6 / 3
buys / sells
$24K–$185K
disclosed value

Price and trade timing

When members traded NVS, against its weekly closing price.

$47.3$105$164201620182020202220242026
bought sold weekly close, split-adjusted

Markers sit on the date the trade happened; it was disclosed up to 45 days later. Prices are weekly closes adjusted for splits and dividends. Shown as context for the public record — we do not calculate returns or performance for any member, and none of this is investment advice.

Who trades it most

4 trades2 buy2 sell
2 trades2 buy0 sell
2 trades2 buy0 sell
1 trade0 buy0 sell
1 trade0 buy1 sell

NVS trades by year

1
16
2
17
2
18
3
19
2
26

Every disclosed NVS trade

Newest first, through July 24, 2026. Each row links to the original filing. 2 of these were filed after the 45-day deadline.

MemberTypeAmountTradedFiling
Alan ArmstrongRBuyLate$1,001 - $15,000March 31, 2026View
Alan ArmstrongRBuyLate$15,001 - $50,000March 30, 2026View
Jacky RosenDExchange$1,001 - $15,000April 8, 2019View
Bill CassidyRSell$1,001 - $15,000April 5, 2019View
Bill CassidyRBuy$1,001 - $15,000January 25, 2019View
Bill CassidyRSell$1,001 - $15,000December 7, 2018View
Shelley Moore CapitoRBuy$1,001 - $15,000April 24, 2018View
Angus S. King, Jr.ISell$1,001 - $15,000November 10, 2017View
Shelley Moore CapitoRBuy$1,001 - $15,000September 5, 2017View
Bill CassidyRBuy$1,001 - $15,000March 31, 2016View

Public STOCK Act disclosures (U.S. Senate eFD and House Clerk), shown for transparency and education — not investment advice, and not a statement of what any member currently owns. Back to the full Congress trades tracker.